✦ LIBER ✦

Pathological features of breast and ovarian cancers inRAD51Cgermline mutation carriers

✍ Scribed by Heidrun Gevensleben,Verena Bossung,Alfons Meindl…

Book ID: 126343176
Publisher: Springer
Year: 2014
Tongue: English
Weight: 107 KB
Volume: 465
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s00428-014-1619-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DeleteriousRAD51Cgermline mutations rare

DeleteriousRAD51Cgermline mutations rarely predispose to breast and ovarian cancer in Pakistan

✍ Rashid, Muhammad U.; Muhammad, Noor; Faisal, Saima; Amin, Asim; Hamann, Ute 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 289 KB

RAD51Cgermline mutations found in Spanis

RAD51Cgermline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families

✍ Ana Blanco,Sara Gutiérrez-Enríquez… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 285 KB

Estrogen receptor positive breast cancer

Estrogen receptor positive breast cancers inBRCA1mutation carriers: clinical risk factors and pathologic features

✍ Nadine Tung, Yihong Wang, Laura C Collins, Jennifer Kaplan… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 263 KB

Analysis of RAD51C germline mutations in

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

✍ ER Thompson; SE Boyle; J Johnson; GL Ryland; S Sawyer; DY Choong; kConFab; G Che 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 80 KB

Analysis of RAD51C germline mutations in

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

✍ Ella R. Thompson; Samantha E. Boyle; Julie Johnson; Georgina L. Ryland; Sarah Sa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

There is strong evidence that overtly inactivating mutations in RAD51C predispose to hereditary breast and ovarian cancer but the prevalence of such mutations, and whether they are associated with a particular clinical phenotype, remains unclear. Resolving these questions has important implications

Parity and the risk of breast and ovaria

Parity and the risk of breast and ovarian cancer inBRCA1andBRCA2mutation carriers

✍ Roger L. Milne; Ana Osorio; Teresa Ramón y Cajal; Montserrat Baiget; Adriana Las 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 215 KB